August 24, 2026

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings Propel Investor Confidence

Tenet Healthcare Corporation (NYSE: THC) continues to capture investor attention as one of the leading players in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Dallas,..

Axsome Therapeutics (AXSM) Stock Analysis: Navigating a 37% Potential Upside with Robust CNS Portfolio

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing investor attention with its promising pipeline and robust market position in the biopharmaceutical sector. Focused on developing innovative therapies for central nervous system..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Promising 72.76% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, is attracting investor attention with its high potential upside of 72.76%. As a biopharmaceutical company, ADMA focuses on..

HealthEquity, Inc. (HQY) Stock Analysis: A Potential 12.45% Upside Amid Strong Buy Ratings

Investors seeking opportunities in the healthcare sector might find HealthEquity, Inc. (HQY) an intriguing option, especially given the unanimous buy ratings and a potential upside of 12.45%. As a leader..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Navigating a 47% Upside Potential Amidst Challenges

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) sits at a critical juncture for investors with a potential upside of 47.3% based on current analyst target averages. As a key player in the..

Waystar Holding Corp. (WAY): Analyst Consensus Points to 32.64% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors with its promising position in the healthcare sector, specifically within the health information services industry. As a company that..

Telix Pharmaceuticals (TLX): Investor Outlook on a Biotech Powerhouse with 87% Potential Upside

Telix Pharmaceuticals Limited (TLX) is carving a niche in the innovative field of radiopharmaceuticals, with a specific focus on therapeutic and diagnostic solutions. With an impressive market capitalization of $3.84..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and an 18% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands out in the healthcare sector, not just for its extensive portfolio of medical and pharmaceutical distribution services but also for its promising stock performance...

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating Growth, Valuation, and Dividend Potential

Fresenius Medical Care AG (NYSE: FMS), a major player in the healthcare sector specializing in medical care facilities, offers a compelling investment narrative for those interested in the renal care..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 20.60% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the home and alternate site infusion services industry, presents a compelling case for investors seeking opportunities in the healthcare sector. With..

Genmab A/S (GMAB): Analyst Ratings Signal 16% Upside Potential in Biotech Growth Play

Genmab A/S (GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of antibody-based products aimed at treating cancer and other serious diseases. Headquartered..

Henry Schein, Inc. (HSIC) Stock Report: Analyst Consensus Points to 10.95% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the healthcare sector with a specific focus on medical distribution, currently commands a market capitalization of $9.86 billion. The company’s stock..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.56% Potential Upside in the Healthcare Sector

Doximity, Inc. (DOCS) stands at the intersection of healthcare and technology, providing a digital platform that connects medical professionals across the United States. With a market capitalization of $4.51 billion,..

Grifols, S.A. (GRFS) Investor Outlook: A Potential 35.81% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, stands out with its robust product lineup and international reach. As a Spanish company specializing in plasma-derived medicines, Grifols..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Challenging Landscape with a Strategic Vision

Avantor, Inc. (AVTR), operating in the dynamic healthcare sector, stands as a formidable player in the medical instruments and supplies industry. With a market capitalization of $9.78 billion, the company..

Corcept Therapeutics (CORT) Stock Analysis: Revenue Growth, Target Price, and Investor Insights

Investors eyeing the healthcare sector, particularly in biotechnology, might find Corcept Therapeutics Incorporated (NASDAQ: CORT) an intriguing prospect. With a market capitalization of $13.22 billion, Corcept is a formidable player..

Regencell Bioscience Holdings L (RGC): Navigating the Volatility in Healthcare Bioscience

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at an intriguing crossroads, offering both volatility and opportunity in the ever-evolving healthcare sector. As a Hong Kong-based Traditional Chinese Medicine (TCM) bioscience..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Strong Buy with a 9.86% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a leading Italian company in the healthcare sector, continues to capture investor attention with its robust market position and promising growth prospects in the medical..

Bio-Techne Corp (TECH) Stock Analysis: Insights into the Biotechnology Leader’s Modest Growth and Solid Market Position

Bio-Techne Corp (NASDAQ: TECH), a key player in the biotechnology industry, offers a compelling investment narrative for those seeking exposure to the healthcare sector. With a market capitalization of $11.27..

Search

Funds

August 24, 2026

Search

Funds

August 24, 2026

FTSE 100

Funds